Skip to content
healthcare.dev
Get a free key

Motion Sickness

NDC 11673-198, Dimenhydrinate, tablet, from Target Corporation.

Product NDC
11673-198
Status
Listed
Labeler
Target Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M009
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-198 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIMENHYDRINATE50 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
11673-198-02116730198022 BLISTER PACK in 1 CARTON (11673-198-02) / 6 TABLET in 1 BLISTER PACK
11673-198-08116730198084 BLISTER PACK in 1 CARTON (11673-198-08) / 6 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-198 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-198 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-198. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.